TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $33.6K2012: $7.0K2013: $31.0K2014: $873.0K2015: $325.0K2016: $94.0K2017: $19.0K2018: $151.0K2019: $953.0K2020: $869.0K2021: $02022: $02023: $02024: $317.0K2025: $0$0
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$317.0K—
2023$0—
2022$0—
2021$0-100.0%
2020$869.0K-8.8%
2019$953.0K+531.1%
2018$151.0K+694.7%
2017$19.0K-79.8%
2016$94.0K-71.1%
2015$325.0K-62.8%
2014$873.0K+2716.1%
2013$31.0K+342.9%
2012$7.0K-79.2%
2011$33.6K—